205 related articles for article (PubMed ID: 32568218)
1. Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model.
Bikou O; Hajjar RJ; Hadri L; Sassi Y
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32568218
[TBL] [Abstract][Full Text] [Related]
2. Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
Zungu-Edmondson M; Shults NV; Melnyk O; Suzuki YJ
PLoS One; 2017; 12(8):e0182551. PubMed ID: 28809956
[TBL] [Abstract][Full Text] [Related]
3. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
[TBL] [Abstract][Full Text] [Related]
4. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
[TBL] [Abstract][Full Text] [Related]
6. The Sugen/Hypoxia Rat Model for Pulmonary Hypertension and Right Heart Failure.
Bikou O; Sassi Y
Methods Mol Biol; 2024; 2803():163-172. PubMed ID: 38676892
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan.
Clements RT; Vang A; Fernandez-Nicolas A; Kue NR; Mancini TJ; Morrison AR; Mallem K; McCullough DJ; Choudhary G
Circ Heart Fail; 2019 Nov; 12(11):e005819. PubMed ID: 31707802
[TBL] [Abstract][Full Text] [Related]
8. Alterations in cardiovascular function in an experimental model of lung fibrosis and pulmonary hypertension.
Darwiche T; Collum SD; Bi W; Reynolds JO; Wilson C; Wareing N; Hernandez AM; Mertens TCJ; Zhou Z; Pandit LM; Karmouty-Quintana H
Exp Physiol; 2019 Apr; 104(4):568-579. PubMed ID: 30663834
[TBL] [Abstract][Full Text] [Related]
9. SU5416 does not attenuate early RV angiogenesis in the murine chronic hypoxia PH model.
Peloquin GL; Johnston L; Damarla M; Damico RL; Hassoun PM; Kolb TM
Respir Res; 2019 Jun; 20(1):123. PubMed ID: 31208454
[TBL] [Abstract][Full Text] [Related]
10. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.
Liu A; Schreier D; Tian L; Eickhoff JC; Wang Z; Hacker TA; Chesler NC
Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H273-83. PubMed ID: 24906919
[TBL] [Abstract][Full Text] [Related]
11. Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416.
Woo E; Kato R; Imano H; Fujiwara Y; Ijiri Y; Okada Y; Yamaguchi T; Izumi Y; Yoshiyama M; Katsumata T; Hayashi T
Curr Vasc Pharmacol; 2017; 15(6):589-598. PubMed ID: 28460626
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
13. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
Leong ZP; Hikasa Y
Vascul Pharmacol; 2018 Nov; 110():31-41. PubMed ID: 30071297
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension.
Iglarz M; Landskroner K; Bauer Y; Vercauteren M; Rey M; Renault B; Studer R; Vezzali E; Freti D; Hadana H; Schläpfer M; Cattaneo C; Bortolamiol C; Weber E; Whitby BR; Delahaye S; Wanner D; Steiner P; Nayler O; Hess P; Clozel M
J Cardiovasc Pharmacol; 2015 Nov; 66(5):457-67. PubMed ID: 26230396
[TBL] [Abstract][Full Text] [Related]
15. The Sugen 5416/Hypoxia Mouse Model of Pulmonary Arterial Hypertension.
Bueno-Beti C; Hadri L; Hajjar RJ; Sassi Y
Methods Mol Biol; 2018; 1816():243-252. PubMed ID: 29987825
[TBL] [Abstract][Full Text] [Related]
16. A novel rat model of pulmonary hypertension induced by mono treatment with SU5416.
Chen Y; Kuang M; Liu S; Hou C; Duan X; Yang K; He W; Liao J; Zheng Q; Zou G; Chen H; Yan H; Chen J; Li Y; Zhou Y; Luo X; Jiang Q; Tang H; Lu W; Wang J
Hypertens Res; 2020 Aug; 43(8):754-764. PubMed ID: 32472112
[TBL] [Abstract][Full Text] [Related]
17. Detrimental Impact of Vasopressin V2 Receptor Antagonism in a SU5416/Hypoxia/Normoxia-Exposed Rat Model of Pulmonary Arterial Hypertension.
Goto I; Dohi K; Ogihara Y; Okamoto R; Yamada N; Mitani Y; Ito M
Circ J; 2016; 80(4):989-97. PubMed ID: 26924211
[TBL] [Abstract][Full Text] [Related]
18. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.
Bogaard HJ; Natarajan R; Mizuno S; Abbate A; Chang PJ; Chau VQ; Hoke NN; Kraskauskas D; Kasper M; Salloum FN; Voelkel NF
Am J Respir Crit Care Med; 2010 Sep; 182(5):652-60. PubMed ID: 20508210
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined angiotensin II receptor antagonism and neprilysin inhibition in experimental pulmonary hypertension and right ventricular failure.
Andersen S; Axelsen JB; Ringgaard S; Nyengaard JR; Hyldebrandt JA; Bogaard HJ; de Man FS; Nielsen-Kudsk JE; Andersen A
Int J Cardiol; 2019 Oct; 293():203-210. PubMed ID: 31307846
[TBL] [Abstract][Full Text] [Related]
20. Continuous inhalation of carbon monoxide induces right ventricle ischemia and dysfunction in rats with hypoxic pulmonary hypertension.
Gautier M; Antier D; Bonnet P; Le Net JL; Hanton G; Eder V
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1046-52. PubMed ID: 17483237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
